Double Blind Bio is an AI-powered clinical trial site automation platform reducing feasibility and enrollment burdens.
Double Blind Bio has raised $5.6M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Double Blind Bio is headquartered in San Francisco, United States.
Double Blind Bio is an AI-powered clinical trial site automation platform reducing feasibility and enrollment burdens.
Double Blind Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Double Blind Bio — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/double-blind-bio. Accessed August 22, 2026.
VCBacked. (2025). Double Blind Bio — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/double-blind-bio
{{cite web |title=Double Blind Bio — Funding & Investors |url=https://www.vcbacked.co/company/double-blind-bio |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated